Víctor M. Villalobos

机构：Johnson & Johnson (United States) · ORCID：0000-0002-8722-284X

发表论文 120 篇 · 总被引 4770 次 · h-index 32

代表论文

• Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study (2021 · Journal of Clinical Oncology · 被引 118)
• First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors (2021 · Clinical Cancer Research · 被引 86)
• Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study (2025 · Journal of Clinical Oncology · 被引 36)
• Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma (2020 · Cancer · 被引 20)
• Phase (Ph) 1b/2 evaluation of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcoma (STS). (2021 · Journal of Clinical Oncology · 被引 9)
• Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis (2020 · Cancer Chemotherapy and Pharmacology · 被引 7)